Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase NA 1Phase 2/3 1

Status

Unknown 3Completed 2Withdrawn 1

Sponsor Class

OTHER 2UNKNOWN 1OTHER_GOV 1NETWORK 1INDUSTRY 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6

Conditions

Breast Neoplasms 478Carcinoma, Non-Small-Cell Lung 436Prostatic Neoplasms 277Lung Neoplasms 169Stomach Neoplasms 138Neoplasms 112Squamous Cell Carcinoma of Head and Neck 108Head and Neck Neoplasms 96Neoplasm Metastasis 92Esophageal Neoplasms 70Ovarian Neoplasms 56Pancreatic Neoplasms 41Sarcoma 39Urinary Bladder Neoplasms 38Nasopharyngeal Carcinoma 32Carcinoma, Squamous Cell 30Triple Negative Breast Neoplasms 28Carcinoma, Ovarian Epithelial 28Adenocarcinoma of Lung 27Adenocarcinoma 27Esophageal Squamous Cell Carcinoma 25Parkinson Disease 4, Autosomal Dominant Lewy Body 23Carcinoma, Transitional Cell 23Adenocarcinoma Of Esophagus 23Breast Neoplasms, Male 22Recurrence 21Unspecified Adult Solid Tumor, Protocol Specific 20Inflammatory Breast Neoplasms 20Fallopian Tube Neoplasms 20Melanoma 18

Interventions

exemestane 7Trastuzumab 7Anastrozole 7Letrozole 6Docetaxel 6palbociclib 5pyrotinib 4entinostat 4Fulvestrant 4Cyclophosphamide 4ribociclib 3abemaciclib 3Tamoxifen 3Doxorubicin 3pertuzumab 2Sodium Chloride 2Paclitaxel 2Lapatinib 2Gonadotropin-Releasing Hormone 2Exercise 2Everolimus 2Epirubicin 2Drug Evaluation 2Capecitabine 2Botulinum Toxins, Type A 2Aromatase Inhibitors 2AZD9833 2trastuzumab deruxtecan 1taxane 1sacubitril and valsartan sodium hydrate drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Interventional × Breast Diseases × Docetaxel × Clear all
NCT00887536 2022-04-20

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

NSABP Foundation Inc

Phase 3 Completed
1,613 enrolled
Breast

Adenocarcinoma, Breast Diseases, Breast Neoplasms, Carcinoma

NCT01917279 2020-07-23

CAMELLIA

ChineseAMS

Phase 3 Unknown
280 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Skin Diseases

NCT03756064 2019-08-13

Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer

Zhejiang Cancer Hospital

Phase NA Unknown
100 enrolled
Breast

Breast Diseases, Breast Neoplasms

NCT03373708 2017-12-18

Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer

Shandong Cancer Hospital and Institute

Phase 2/3 Unknown
200 enrolled
Breast

Breast Diseases, Breast Neoplasms

NCT01472146 2017-05-09

ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer

Instituto Nacional de Cancer, Brazil

Phase 2 Completed
58 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

NCT00678626 2015-05-04

Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer

Pfizer

Phase 2 Withdrawn
Breast

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡